4888 — Stella Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Stella Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,276	2,710	2,354	3,206	2,823
Net Total Accounts Receivable
Net Total Receivables	16.9	59.3	76.2	715	67.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,175	3,793	3,629	5,243	4,353
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	92	103	81.5	66.5	47.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4,719	4,329	3,821	5,417	4,487
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	308	422	456	390	260
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	1,639	1,577	1,444	2,210	2,060
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	3,080	2,753	2,377	3,207	2,427
Total Liabilities & Shareholders' Equity	4,719	4,329	3,821	5,417	4,487
Total Common Shares Outstanding